Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

AI in the ICU: Algorithm Aims to Guide Glucose Control After Cardiac Surgery

Caitlin E. Cox

June 10, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

Michael O'Riordan

February 07, 2023

News Daily News

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Michael O'Riordan

January 12, 2023

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Daily News

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

Caitlin E. Cox

May 10, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

CABG Provides ‘Good Value’ in Ischemic Cardiomyopathy

Todd Neale

January 26, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

Advertisement

Heart Disease Treatment Costs $100 Billion per Year in the US

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

AI in the ICU: Algorithm Aims to Guide Glucose Control After Cardiac Surgery

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Statins Are Cost-effective in the Elderly

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Prehospital Troponin Testing With EMS Input Could Save a Lot of Money

CT Angiography Is Increasing in England, but Downstream Tests Are Not

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Polypill Bests Usual Care in Patients With Recent MI: SECURE

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

February 2022 News Roundup

CABG Provides ‘Good Value’ in Ischemic Cardiomyopathy

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content